Date Published:
2023 Feb

Publication Type:
Journal Article

Authors:

M. Kohli
A. Fisher
N. Sun-Suslow
A. Heaton
M.S. Dawson
J. Marquie
D.R. Franklin
M. Marquine
J.E. Iudicello
R.K. Heaton
D.J. Moore

Secondary:
J Int Neuropsychol Soc

Volume:
29

Pagination:
193-204

Issue:
2

PMID:
36510855

URL:
https://pubmed.ncbi.nlm.nih.gov/36510855

DOI:
10.1017/S1355617722000777

Keywords:
CHARTER;Internal

Abstract:
<p>OBJECTIVE: To determine the reliability of teleneuropsychological (TNP) compared to in-person assessments (IPA) in people with HIV (PWH) and without HIV (HIV-).METHODS: Participants included 80 PWH (M = 58.7, SD = 11.0) and 23 HIV- (M = 61.9, SD = 16.7). Participants completed two comprehensive neuropsychological IPA before one TNP during the COVID-19 pandemic (March-December 2020). The neuropsychological tests included: Hopkins Verbal Learning Test-Revised (HVLT-R Total and Delayed Recall), Controlled Oral Word Association Test (COWAT; FAS-English or PMR-Spanish), Animal Fluency, Action (Verb) Fluency, Wechsler Adult Intelligence Scale 3 Edition (WAIS-III) Symbol Search and Letter Number Sequencing, Stroop Color and Word Test, Paced Auditory Serial Addition Test (Channel 1), and Boston Naming Test. Total raw scores and sub-scores were used in analyses. In the total sample and by HIV status, test-retest reliability and performance-level differences were evaluated between the two consecutive IPA (i.e., IPA1 and IPA2), and mean in-person scores (IPA-M), and TNP.RESULTS: There were statistically significant test-retest correlations between IPA1 and IPA2 ( or ρ = .603-.883, < .001), and between IPA-M and TNP ( or ρ = .622-.958, < .001). In the total sample, significantly lower test-retest scores were found between IPA-M and TNP on the COWAT (PMR), Stroop Color and Word Test, WAIS-III Letter Number Sequencing, and HVLT-R Total Recall ( < .05). Results were similar in PWH only.CONCLUSIONS: This study demonstrates reliability of TNP in PWH and HIV-. TNP assessments are a promising way to improve access to traditional neuropsychological services and maintain ongoing clinical research studies during the COVID-19 pandemic.</p>